Nuclear retinoic acid receptors (RARs) function as ligand-activated tr
ans-acting transcription factors and mediate the effects of retinoids
on gene expression, cell growth, and differentiation. Determination of
the receptors' expression in premalignant and malignant lesions may p
rovide prognostic value and direct the selection of receptor-specific
retinoids in cancer prevention or treatment. We describe a sensitive a
nd practical in situ hybridization method for the analysis of RARs in
tissue sections of fixed and embedded surgical specimens. Digoxigenin-
labeled antisense and sense RNA probes were prepared for nuclear RAR-a
lpha, RAR-beta, and RAR-gamma. The specificity of the probes for their
respective receptor mRNAs was demonstrated by Northern blot hybridiza
tion to total RNA extracted from murine and human cells. Optimal condi
tions for in situ localization of the RAR mRNA were established using
cultured tumor cells, and these conditions were then used for the dete
ction of RAR mRNA in formalin-fixed, paraffin-embedded sections of sur
gical specimens from human tumors. The hybridization stain was detecte
d in the cytoplasm (where it was expected to be localized) and not see
n in the cell nucleus. This method provides a rapid detection procedur
e with good resolution that allows one to clearly distinguish strongly
and weakly stained cells. A comparison of receptor expression in head
and neck squamous carcinoma specimens and in adjacent normal tissues
revealed a significant decrease in the level of RAR-beta mRNA in the t
umor cells.